Columbus, OH, United States of America

Roger Briesewitz

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Roger Briesewitz

Introduction

Roger Briesewitz is an accomplished inventor based in Columbus, Ohio. He has made significant contributions to the field of pharmaceuticals, particularly in the development of small molecule Ras inhibitors. With a total of three patents to his name, Briesewitz is recognized for his innovative approaches to treating various diseases.

Latest Patents

Briesewitz's latest patents focus on novel compounds that act as Ras inhibitors. These patents disclose compositions that include these compounds and methods for using them in the treatment of various diseases. Additionally, one of his patents describes an antibody-drug conjugate that combines an antibody with a compound aimed at enhancing therapeutic efficacy. Another aspect of his work involves pharmaceutical compositions that incorporate these compounds or antibody-drug conjugates, along with methods for treating cancer by administering a therapeutically effective amount to patients in need.

Career Highlights

Roger Briesewitz is affiliated with the Ohio State Innovation Foundation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment and other medical applications.

Collaborations

Briesewitz collaborates with notable colleagues, including Dehua Pei and Punit Upadhyaya, who contribute to his innovative projects and research initiatives.

Conclusion

Roger Briesewitz exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking work on Ras inhibitors and related compounds. His contributions are paving the way for new treatment options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…